SIP Trunking

SIP Trunking Industry News

TMCNet: U.S. Patents Awarded to Inventors in Florida (Aug. 27)

[August 27, 2011]

U.S. Patents Awarded to Inventors in Florida (Aug. 27)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Aug. 27 -- The following federal patents were awarded to inventors in Florida.

*** University of New York Assigned Patent ALEXANDRIA, Va., Aug. 27 -- The University of New York, Amherst, N.Y., has been assigned a patent (8,003,979) developed by five co-inventors for a "high density coupling of quantum dots to carbon nanotube surface for efficient photodetection." The co-inventors are Namchul Cho, Daejeon, South Korea, Kaushik Roy Choudhury, Gainesville, Fla., Yudhisthira Sahoo, Amherst, N.Y., Kwang Sup Lee, Daejeon, South Korea, and Paras N. Prasad, Williamsville, N.Y.


The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to a method of preparing a carbon nanotube-quantum dot conjugate having a high density of quantum dots (QDs) on its surface. This method involves providing a plurality of semiconductor quantum dots and providing a thiol-functionalized carbon nanotube having a plurality of terminal thiol groups on its surface. The plurality of semiconductor quantum dots are attached to the surface of the carbon nanotube under conditions effective to yield a carbon nanotube-quantum dot conjugate having a high density of quantum dots on its surface. The present invention also relates to a carbon nanotube-quantum dot conjugate having a high density of quantum dots on its surface. The present invention further relates to a photodetector device. This device includes a substrate and a nanocomposite layer. The nanocomposite layer includes a plurality of the carbon nanotube-quantum dot conjugates previously described." The patent application was filed on Feb. 12, 2007 (11/673,850). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,003,979&OS=8,003,979&RS=8,003,979 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Florida Inventor Develops Patent for Integrated Automotive Horn/Light Apparatus and Method ALEXANDRIA, Va., Aug. 27 -- Robert Cannella, Delray Beach, Fla., has developed a patent (8,003,902) for an "integrated automotive horn/light apparatus and method." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An apparatus and method for simultaneously operating the horn and light systems of a motorized vehicle is provided. The controller used to operate the systems can be a single controller that operates the horn when a certain range of pressure is applied to the controller and operates the horn and lights systems when a stronger pressure is applied. The system can include a dedicated horn operating system controller independent of the dual function controller to eliminate the need for differing pressures to operate the horn and light systems substantially simultaneously." The patent application was filed on Jan. 9, 2008 (12/008,225). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,003,902&OS=8,003,902&RS=8,003,902 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Goodrich Assigned Patent ALEXANDRIA, Va., Aug. 27 -- Goodrich, Charlotte, N.C., has been assigned a patent (8,003,947) developed by Alexander Majewski, Fairfield, Conn., and Rene Abreu, The Villages, Fla., for a "system and method for magnitude and phase retrieval by path modulation." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A system includes a transmitter is configured to transmit an electromagnetic signal through a sample cell (including a sample medium) to a receiver, which is configured to receive the electromagnetic signal and another electromagnetic signal for mixing therewith. Propagation paths of the signals to the transmitter and receiver include a first propagation path of the electromagnetic signal to the transmitter, and a second propagation path of the other electromagnetic signal to the receiver. The arrangement, which is located along either or each of the propagation paths of signals to the transmitter and receiver, is configured to alter the length of a respective propagation path. And the processor configured to recover an amplitude and phase of the transmitted electromagnetic signal, and calculate a complex index of refraction of the sample medium as a function of the amplitude and phase of the transmitted electromagnetic signal." The patent application was filed on Feb. 25, 2010 (12/712,736). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,003,947&OS=8,003,947&RS=8,003,947 Written by Satyaban Rath; edited by Hemanta Panigrahi.

*** Sanofi Pasteur Vaxdesign Assigned Patent ALEXANDRIA, Va., Aug. 27 -- Sanofi Pasteur Vaxdesign, Orlando, Fla., has been assigned a patent (8,003,387) developed by twelve co-inventors for an "in vitro germinal centers." The co-inventors are Selva Sukumar, Berkeley, Calif., Mohey Eldin M. El Shikh, Richmond, Va., John G. Tew, Mechanicsville, Va., Guzman Sanchez-Schmitz, Orlando, Fla., Donald Drake III, Orlando, Fla., Luis Mosquera, Oviedo, Fla., Eric Mishkin, Winter Springs, Fla., Anatoly M. Kachurin, Orlando, Fla., Russell Higbee, Orlando, Fla., Conan Li, Los Altos, Calif., William L. Warren, Orlando, Fla., and Heather Fahlenkamp, Cleveland.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention incorporates germinal centers (GCs) into three-dimensional (3D) engineered tissue constructs (ETCs). In an embodiment, we have incorporated the GC in the design of an artificial immune system (AIS) to examine immune responses to vaccines and other compounds. Development of an in vitro GC adds functionality to an AIS, in that it enables generation of an in vitro human humoral response by human B lymphocytes that is accurate and reproducible, without using human subjects. The invention also permits evaluation of, for example, vaccines, allergens, and immunogens, and activation of human B cells specific for a given antigen, which can then be used to generate human antibodies. In an embodiment of the present invention the function of the in vitro GC is enhanced by placing FDCs and other immune cells in a 3D ETC; FDCs appear more effective over a longer time (antibody production is sustained for up to about 14 days." The patent application was filed on Dec. 21, 2006 (11/642,938). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=80,03,387.PN.&OS=PN/80,03,387&RS=PN/80,03,387 Written by Ruby Maibam; edited by Jaya Anand.

*** University of California Assigned Patent ALEXANDRIA, Va., Aug. 27 -- The University of California, Oakland, Calif., has been assigned a patent (8,003,376) developed by Mack J. Fulwyler, Sarasota, Fla., and Joe W. Gray, San Francisco, for a "capillary array and related methods." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides methods and devices for detecting the presence of one or more target analytes in a sample employing a channel having affixed therein one or more binding partners for each target analyte. Assays are carried out by transporting the sample through the channel to each successive binding partner so that target analyte present in said sample binds to the corresponding binding partner. The sample is then transported beyond the binding partner(s), followed by detection of any target analyte bound to each binding partner. In one embodiment, binding efficiency is increased by the use of segmented transport, wherein a first bolus or bubble of a fluid that is immiscible with the sample precedes the sample during transport and a second bolus or bubble of a fluid that is immiscible with the sample follows the sample. Many configurations are possible for the device of the invention. A preferred device includes: a substrate with a channel formed in its surface, and a cover element that overlies and seals the channel. Binding partner(s) are affixed to the surface of the cover element facing the channel lumen." The patent application was filed on May 5, 2010 (12/774,679). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=80,03,376.PN.&OS=PN/80,03,376&RS=PN/80,03,376 Written by Ruby Maibam; edited by Jaya Anand.

*** Eaton Assigned Patent ALEXANDRIA, Va., Aug. 27 -- Eaton, Cleveland, has been assigned a patent (8,004,283) developed by Patrick W. Mills, Bradenton, Fla., Richard G. Benshoff, Sarasota, Fla., and James M. McCormick, Bradenton, Fla., for a "method of actuating a test function of an electrical switching apparatus at a panel and electrical switching apparatus employing the same." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An arc fault circuit breaker includes a panel having a first side and an opposite second side, a housing coupled to the opposite second side of the panel, separable contacts, an operating mechanism structured to open and close the separable contacts, and a trip mechanism cooperating with the operating mechanism to trip open the separable contacts. The trip mechanism includes a test circuit structured to simulate a trip condition to trip open the separable contacts, and a proximity sensor disposed on or within the housing proximate the opposite second side of the panel. The proximity sensor is structured to sense a target to actuate the test circuit when the target is disposed proximate the first side of the panel and opposite the proximity sensor." The patent application was filed on Jan. 25, 2008 (12/019,794). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,004,283.PN.&OS=PN/8,004,283&RS=PN/8,004,283 Written by Anjali Jha; edited by Jaya Anand.

*** Tautatis Assigned Patent ALEXANDRIA, Va., Aug. 27 -- Tautatis, Cambridge, Mass., has been assigned a patent (8,003,631) developed by Hanno Roder, Jacksonville, Fla., for a "composition and method for the treatment of tauopathies." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention refers to the use of a specific indolocarbazole compound of general formula (1) or a pharmaceutically-acceptable a salt thereof for the preparation of a pharmaceutical composition for the prevention or treatment of a neurodegenerative and/or dementing illness driven by the molecular pathology of microtubule-associate tau such as Alzheimer's disease, frontal lobe dementia, Pick's disease, Parkinson disease with dementia, corticobasal degeneration, argyrophilic grains disease, or supranuclear palsy. A method for treating or preventing such illnesses is also disclosed. Furthermore, methods for the identification of efficacious inhibitors of neurofibrillary degeneration, and methods for the determination of an appropriate dosage of an inhibitor of the PHF-type tau hyperphosphorylation for the treatment of a condition characterized by neurofibrillary pathology are described." The patent application was filed on May 26, 2005 (11/597,771). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=80,03,631.PN.&OS=PN/80,03,631&RS=PN/80,03,631 Written by Rajat Puri; edited by Jaya Anand.

*** Florida State University Research Foundation Assigned Patent ALEXANDRIA, Va., Aug. 27 -- Florida State University Research Foundation, Tallahassee, Fla., has been assigned a patent (8,003,812) developed by Robert A. Holton, Tallahassee, Fla., and Phong Vu, Tallahassee, Fla., for a "C10 cyclopentyl ester substituted taxanes." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A taxane having a cyclopentyl ester substituent at C10, a keto substituent at C9, a hydroxy substituent at C2, a 2-thienyl substituent at C3' and an isopropoxycarbamate substituent at C3'." The patent application was filed on Aug. 10, 2009 (12/538,409). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,003,812.PN.&OS=PN/8,003,812&RS=PN/8,003,812 Written by Kusum Sangma; edited by Anand Kumar.

*** Sanofi Pasteur Vax Design Assigned Patent for in Vitro Germinal Centers ALEXANDRIA, Va., Aug. 27 -- Sanofi Pasteur Vax Design, Orlando, Fla., has been assigned a patent (8,003,385) developed by twelve co-inventors for an "in vitro germinal centers." The co-inventors are Selva Sukumar, Berkeley, Calif., Mohey Eldin M. El Shikh, Richmond, Va., John G. Tew, Mechanicsville, Va., Guzman Sanchez-Schmitz, Orlando, Fla., Donald Drake III, Orlando, Fla., Luis Mosquera, Oviedo, Fla., Conan Li, Los Altos, Calif., Anatoly M. Kachurin, Orlando, Fla., Russell Higbee, Orlando, Fla., Heather Fahlenkamp, Cleveland, Eric Mishkin, Winter Springs, Fla., and William L. Warren, Orlando, Fla.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention incorporates germinal centers (GCs) into three-dimensional (3D) engineered tissue constructs (ETCs). In an embodiment, we have incorporated the GC in the design of an artificial immune system (AIS) to examine immune responses to vaccines and other compounds. Development of an in vitro GC adds functionality to an AIS, in that it enables generation of an in vitro human humoral response by human B lymphocytes that is accurate and reproducible, without using human subjects. The invention also permits evaluation of, for example, vaccines, allergens, and immunogens, and activation of human B cells specific for a given antigen, which can then be used to generate human antibodies. In an embodiment of the present invention the function of the in vitro GC is enhanced by placing FDCs and other immune cells in a 3D ETC; FDCs appear more effective over a longer time (antibody production is sustained for up to about 14 days." The patent application was filed on Feb. 17, 2010 (12/707,563). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=80,03,385.PN.&OS=PN/80,03,385&RS=PN/80,03,385 Written by Ruby Maibam; edited by Jaya Anand.

*** University of South Florida Assigned Patent ALEXANDRIA, Va., Aug. 27 -- The University of South Florida, Tampa, Fla., has been assigned a patent (8,003,778) developed by John H. Paul, St. Petersburg, Fla., Mike Gray, St. Petersburg, Fla., and Erica Casper, St. Petersburg, Fla., for a "detection of red tide organisms by nucleic acid amplification." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A real-time reverse transcription-PCR, or NABSA, method (and associated primers) targeting the rbcL gene for the detection and quantitation of the Florida red tide organism, Karenia brevis." The patent application was filed on March 16, 2010 (12/724,854). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,003,778&OS=8,003,778&RS=8,003,778 Written by Kusum Sangma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1059026 (c) 2011 Targeted News Service

[ Back To SIP Trunking Home's Homepage ]
+ Return to SIP Trunking Home


Videos
Resources
Presenting the New Ingate/Intertex Website: Internet+ is an extended Internet access allowing high quality SIP (Session Initiation Protocol) based real-time person-to-person communication, everywhere and for any application. It applies to both fixed and mobile networks ...
+ Visit Now
What's New?
Blogs
eBOOKS
WHITEPAPERS
Webinars
Podcasts
CASE STUDIES
DATASHEETS